Intravenous (IV) Iron Drugs In Global Market by Value, Therapeutic Application & Product Type: Oncology & Cardiology Segments are Witnessing Fastest Growth

Researchmoz added Most up-to-date research on "Intravenous (IV) Iron Drugs In Global Market by Value, Therapeutic Application & Product Type: Oncology & Cardiology Segments are Witnessing Fastest Growth" to its huge collection of research reports.

Intravenous (IV) Iron Drugs In Global Market

Iron is vital for multiple bodily functions, most importantly for the production of hemoglobin for red blood cells which are responsible for transporting oxygen in the blood. As an element, the only source of iron is from the diet. There is no way the body can produce iron itself. Intravenous (IV) treatment, in a broad sense, covers all the types of medications delivered intravenously, i.e. directly into the vein, through intravenous drip. Compared to the other routes of infusing medications, the intravenous route is the fastest way to deliver fluids and medications throughout the body. The first iron product for intravenous use was high-molecular-weight iron dextran. Some of the major areas of IV iron application include gynecology, gastroenterology, oncology and surgeries. Hemoglobin, Ferritin, Transferrin, and Hepcidin are major molecules which are critical in the function and regulation of iron.

The key factors driving growth of the global I.V. iron industry include increase in number of dialysis cases, increasing global healthcare expenditures, rising ageing population, increasing life expectancy rate, growing number of ERSD patients and rising medicines expenditures. Some of the noteworthy trends and developments of this industry are new product development, introduction of the first generation drugs InFed (iron dextran) and Dexeferrum (iron dextra) and feraccru treatment penetration. However, the growth of this sector is being hindered by emerging anemia management therapies and associated risks.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=731843

The report analyzes the global iron products industry along with an extensive coverage of global, Europe and the US I.V. iron market. The global IV iron market witnesses intense competition with numerous top notch players; such as Galenica Pharmaceuticals, Actavis Inc, AMAG Pharmaceuticals; operating in the marketplace along with small budding players. As a part of analysis of fierce competition prevailing in the industry, product contention has been presented in the report. The company profiles of leading aforementioned players in the market are also incorporated in the report.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Browse TOC @ https://www.researchmoz.us/global-intravenous-iv-iron-drugs-market-report-2016-edition-report.html/toc

Table of Content

1. Iron in Human Body: An Introduction
1.1 I.V. Iron Application Areas  
1.1.1 I.V. Iron Application in Nephrology
1.2 Iron Deficiency - Anemia  
1.2.1 Iron Deficiency Metrics  
1.3 I.V. Iron Therapies for Anemia Treatment  
1.4 Types of I.V. Iron

2. Global Iron Product Market Analysis
2.1 Global Iron Product Market by Value  
2.2 Global Iron Products Market Share by Segment

3. Global I.V. Iron Drugs Market Analysis
3.1 Global I.V. Iron Drugs Market by Value  
3.2 Global I.V. Iron Drugs Market by Product  
3.3 Global I.V. Iron Drugs Market Share by Product

4. I.V. Iron Drugs Regional Market Analysis
4.1 European I.V. Iron Drug Market  
4.1.1 European I.V. Iron Drug Market by Value  
4.1.2 European I.V. Iron Drug Market by Product  
4.1.3 European I.V. Iron Drug Market Share by Product
4.2 The US I.V. Iron Drug Market  
4.2.1 The US I.V. Iron Drug Market by Value